Citations (3)
Keep up to date with the latest research on this topic with citation updates for this article.
Hematology
Volume 27, 2022 - Issue 1
Research Article
Updated recommendations on the use of ruxolitinib for the treatment of myelofibrosis
Timothy Devosa Department of Hematology, University Hospitals Leuven (UZ Leuven) and Department of Microbiology and Immunology, Laboratory of Molecular Immunology (Rega Institute), Catholic University Leuven (KU Leuven), Leuven, BelgiumCorrespondence[email protected]
https://orcid.org/0000-0002-6881-417XView further author information
https://orcid.org/0000-0002-6881-417XView further author information, , , Violaine Havelanged Department of Hematology, Cliniques universitaires Saint-Luc, Brussels, Belgiumhttps://orcid.org/0000-0001-6061-6315View further author information
https://orcid.org/0000-0001-6061-6315View further author information & Fleur Samantha Benghiate Department of Hemato-Oncology, Erasme Hospital, Brussels, Belgiumhttps://orcid.org/0000-0002-2521-238XView further author information
https://orcid.org/0000-0002-2521-238XView further author information